Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:520273rdf:typepubmed:Citationlld:pubmed
pubmed-article:520273lifeskim:mentionsumls-concept:C0439861lld:lifeskim
pubmed-article:520273lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:520273lifeskim:mentionsumls-concept:C0205520lld:lifeskim
pubmed-article:520273lifeskim:mentionsumls-concept:C1512523lld:lifeskim
pubmed-article:520273pubmed:issue4lld:pubmed
pubmed-article:520273pubmed:dateCreated1980-3-17lld:pubmed
pubmed-article:520273pubmed:abstractTextThe authors investigated the pharmacokinetics of the pressor substance 5,8-dimetoxy-trans-2-/2-hydroxyethyl/-amino-3-hydroxy-1,2,3,4-tetrahydronaphthaline hydrochloride (1b), which possessed strong pressor action. Blood concentrations after venous administration in a dose of 1 mg/kg of body weight were determined by means of exctration spectrofluorometric method. The data complied with the biexponential equation, meeting the requirements of an open two-compartment model. There was a quick elimination of the substance from the central compartment, which correlated also with the data for quick disappearances of the effect on the arterial pressure.lld:pubmed
pubmed-article:520273pubmed:languagebullld:pubmed
pubmed-article:520273pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:520273pubmed:citationSubsetIMlld:pubmed
pubmed-article:520273pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:520273pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:520273pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:520273pubmed:statusMEDLINElld:pubmed
pubmed-article:520273pubmed:issn0367-0643lld:pubmed
pubmed-article:520273pubmed:authorpubmed-author:StanevaDDlld:pubmed
pubmed-article:520273pubmed:authorpubmed-author:AstrugAAlld:pubmed
pubmed-article:520273pubmed:authorpubmed-author:Mikha?lovaDDlld:pubmed
pubmed-article:520273pubmed:authorpubmed-author:NachevIIlld:pubmed
pubmed-article:520273pubmed:issnTypePrintlld:pubmed
pubmed-article:520273pubmed:volume18lld:pubmed
pubmed-article:520273pubmed:ownerNLMlld:pubmed
pubmed-article:520273pubmed:authorsCompleteYlld:pubmed
pubmed-article:520273pubmed:pagination229-34lld:pubmed
pubmed-article:520273pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:520273pubmed:meshHeadingpubmed-meshheading:520273-A...lld:pubmed
pubmed-article:520273pubmed:meshHeadingpubmed-meshheading:520273-I...lld:pubmed
pubmed-article:520273pubmed:meshHeadingpubmed-meshheading:520273-B...lld:pubmed
pubmed-article:520273pubmed:meshHeadingpubmed-meshheading:520273-N...lld:pubmed
pubmed-article:520273pubmed:meshHeadingpubmed-meshheading:520273-R...lld:pubmed
pubmed-article:520273pubmed:meshHeadingpubmed-meshheading:520273-M...lld:pubmed
pubmed-article:520273pubmed:meshHeadingpubmed-meshheading:520273-K...lld:pubmed
pubmed-article:520273pubmed:meshHeadingpubmed-meshheading:520273-V...lld:pubmed
pubmed-article:520273pubmed:meshHeadingpubmed-meshheading:520273-T...lld:pubmed
pubmed-article:520273pubmed:meshHeadingpubmed-meshheading:520273-D...lld:pubmed
pubmed-article:520273pubmed:meshHeadingpubmed-meshheading:520273-T...lld:pubmed
pubmed-article:520273pubmed:year1979lld:pubmed
pubmed-article:520273pubmed:articleTitle[Pharmacokinetics of the pressor substance, 5,8-dimethoxy-trans-2-(2-hydroxyethyl)-amino-3-hydroxy-1,2,3,4-tetrahydronaphthalene hydrochloride (1b), after intravenous use].lld:pubmed
pubmed-article:520273pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:520273pubmed:publicationTypeEnglish Abstractlld:pubmed